Search Results 861-870 of 18252 for Immunode

1. A First-in-Human Study Of YL217 In Patients With Advanced Solid Tumors - Mayo Clinic

   * Known human immunodeficiency virus (HIV) infection. * Active hepatitis C infection. Note: Other protocol defined Inclusion/Exclusion Criteria may apply ...

2. Veliparib and Topotecan Hydrochloride in Treating Patients with Solid Tumors, Relapsed or Refractory Ovarian Cancer, or Primary Peritoneal Cancer - Mayo Clinic

   ... immunodeficiency virus (HIV) positive; Receiving any other investigational agent which would be considered as a treatment for the primary neoplasm; Other ...

3. A Study of Rucaparib in Patients With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene Deficiency - Mayo Clinic

   Known human immunodeficiency virus (HIV) or acquired immunodeficiency syndrome (AIDS)-related illness, or history of chronic hepatitis B or C, with the ...

4. A Study to Evaluate INO-3107 with Electroporation (EP) in Participants with HPV-6- and/or HPV-11-Associated Recurrent Respiratory Papillomatosis (RRP) - Mayo Clinic

   Have a diagnosis of immunodeficiency or treatment with systemic immunosuppressive therapy within 28 days prior to the first dose of trial treatment ...

5. Gastroenterology and Hepatology - Clinical trials

   [MUSIC PLAYING]. Joseph Sirven, M.D., Professor of Neurology, Mayo Clinic: Mayo's mission is about the patient. The patient comes first.

6. A Study to Evaluate MUC1 Vaccine to Prevent Lung Cancer in Current and Former Smokers at High Risk for Lung Cancer - Mayo Clinic

   ... immunodeficiency virus (HIV) - Known autoimmune disease - Known non‐alcoholic steatohepatitis (NASH) or non‐alcoholic fatty liver disease (NAFLD) - History ...

7. A Study to Evaluate Testing the Addition of Targeted Radiation Therapy to Surgery and the Usual Chemotherapy Treatment for Stage I-IIIA Malignant Pleural Mesothelioma - Mayo Clinic

   Note that patients who are human immunodeficiency virus (HIV) positive are eligible, provided they are under treatment with highly active antiretroviral ...

8. ETHAN - ET for Male BC - Mayo Clinic

   ... immunodeficiency virus positivity or with known active hepatitis B or C \[for example, hepatitis B surface antigen positive\]. Screening is not required for ...

9. Study of Durvalumab and Tremelimumab as First-line Treatment in Patients With Advanced Hepatocellular Carcinoma (HIMALAYA) - Mayo Clinic

   ... immunodeficiency virus (positive human immunodeficiency virus [HIV] 1/2 antibodies). Current or prior use of immunosuppressive medication within 14 days ...

10. A Study to Evaluate the Effectiveness and Safety of Ralinepag To Improve Treatment Outcomes in Peripheral Arterial Hypertension (PAH) Patients - Mayo Clinic

    Human immunodeficiency virus (HIV) infection; Congenital systemic-pulmonary shunt (must have undergone surgical correction at least 1 year prior to Screening ...